Spironolactone Use and the Risk of Breast Cancer

    Image of study
    TLDR Spironolactone use is not linked to an increased risk of breast cancer, but caution is advised for high-risk patients.
    The document from May 2016 reviewed the potential risk of breast cancer associated with the use of spironolactone, a medication commonly used for conditions like female pattern hair loss, hirsutism, and postadolescent acne due to its anti-androgenic properties. Initial concerns about a link between spironolactone and breast cancer were based on case reports from 1975 and animal model studies suggesting a risk of carcinogenesis. However, more recent studies, including two population-based retrospective cohorts from the United Kingdom and Denmark, as well as a study of 91 women using spironolactone for acne, found no association between spironolactone use and an increased risk of breast cancer after follow-up periods of 4 to 8 years. The conclusion of the document is that current data do not support a link between spironolactone use and the development of breast cancer, but it notes that there is a lack of large, long-term studies specifically investigating this risk in spironolactone users for dermatological conditions. The document suggests caution in prescribing spironolactone to patients with a history of breast cancer or those at higher risk for the disease.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 358 results

      community Spironolactone or bicalutamide prescription

      in Treatment  4 upvotes 1 year ago
      The conversation is about someone seeking a doctor in the EU who prescribes spironolactone or bicalutamide for female pattern hair loss, as they are having difficulty finding treatment options beyond Minoxidil in Austria. They are asking for recommendations and are open to direct messages for assistance.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  53 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Spironolactone for 11 years, finasteride for almost 5 years, started oral minoxidil in November 😢 ended oral contraceptive in Dec.

      in Progress Pictures  224 upvotes 8 months ago
      A user shared their 11-year experience with spironolactone and nearly 5 years with finasteride for hair loss, recently adding oral minoxidil and stopping birth control. Various treatments were discussed, including organic options, checking for underlying health issues, considering dutasteride, and the potential role of progesterone in hair loss.

      community DHT levels after 4 weeks of Fina and 8 weeks of Fina + 4 weeks of Duta

      in Update  35 upvotes 5 years ago
      The user reported early stage diffuse hair thinning and increased DHT levels after 4 weeks on Finasteride and 8 weeks on Finasteride plus 4 weeks on Dutasteride, despite the medications being authentic and stored properly. They are considering increasing their Dutasteride dosage due to the lack of side effects and are unsure if the treatment is helping their hair.

      community Spironolactone Update

      in Female  11 upvotes 7 years ago
      A woman's experience with Spironolactone as treatment for female pattern hair loss, including the effects of increasing dosage and her doctor's recommendation to try finasteride if no results are seen after 6 months. Other users have also shared their experiences with using finasteride for this condition.

    Similar Research

    5 / 1000+ results